BBS-Bioactive Bone S
BBS-Bioactive Bone Substitutes Plc: Financial Statements Bulletin 2023: Preparations for commercial phase initiated (unaudited)
26 févr. 2024 10h45 HE | BBS-Bioactive Bone Substitutes Oyj
BBS-Bioactive Bone Substitutes Plc, Financial Statements Bulletin 2023, 26 February 2024 at 5.45 p.m. (EET) This is a summary of BBS-Bioactive Bone Substitutes Plc’s Financial Statements...
BBS-Bioactive Bone S
BBS-Bioactive Bone Substitutes Oyj: Tilinpäätöstiedote 2023: Kaupallisen vaiheen valmistelut alkaneet (tilintarkastamaton)
26 févr. 2024 10h45 HE | BBS-Bioactive Bone Substitutes Oyj
BBS-Bioactive Bone Substitutes Oyj, Tilinpäätöstiedote, 26.2.2024 klo 17.45 Tämä tiedote on tiivistelmä BBS-Bioactive Bone Substitutes Oyj:n tilinpäätöstiedotteesta tammi–joulukuu 2023. Koko raportti...
Inside information -
Inside information - BBS-Bioactive Bone Substitutes Plc: Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position
21 févr. 2024 03h30 HE | BBS-Bioactive Bone Substitutes Oyj
BBS-Bioactive Bone Substitutes Plc, Company announcement, inside information, 21 February 2024 at 10:30 am EET Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone...
Sisäpiiritieto - BBS
Sisäpiiritieto - BBS-Bioactive Bone Substitutes Oyj on sopinut RiverFortin kanssa rahoitussopimuksen mukaisen ennakkomaksun kolmannen erän nostamisesta yhtiön käyttöpääoman vahvistamiseksi
21 févr. 2024 03h30 HE | BBS-Bioactive Bone Substitutes Oyj
BBS-Bioactive Bone Substitutes Oyj, yhtiötiedote, sisäpiiritieto,  21.2.2024 klo 10.30 BBS-Bioactive Bone Substitutes Oyj on sopinut RiverFortin kanssa rahoitussopimuksen mukaisen ennakkomaksun...
BBS-Bioactive Bone S
BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself
31 janv. 2024 11h00 HE | BBS-Bioactive Bone Substitutes Oyj
BBS-Bioactive Bone Substitutes Plc, Company announcement, 31 January 2024 at 6.00 p.m. EET BBS-Bioactive Bone Substitutes has resolved on a share issue without consideration to the company itself...
BBS-Bioactive Bone S
BBS-Bioactive Bone Substitutes Oyj on päättänyt maksuttomasta osakeannista itselleen
31 janv. 2024 11h00 HE | BBS-Bioactive Bone Substitutes Oyj
BBS-Bioactive Bone Substitutes Oyj, yhtiötiedote, 31.1.2024 klo 18.00 BBS-Bioactive Bone Substitutes on päättänyt maksuttomasta osakeannista itselleen BBS-Bioactive Bone Substitutes Oyj:n...
BBS-Bioactive Bone S
BBS-Bioactive Bone Substitutes Plc: Kimmo Tyni appointed as Product Director of BBS-Bioactive Bone Substitutes Plc
02 janv. 2024 09h30 HE | BBS-Bioactive Bone Substitutes Oyj
BBS-Bioactive Bone Substitutes Plc, Company Announcement, 2 January 2024 at 04.30 PM (EET) Kimmo Tyni appointed as Product Director of BBS-Bioactive Bone Substitutes Plc BBS-Bioactive Bone...
BBS-Bioactive Bone S
BBS-Bioactive Bone Substitutes Oyj: Kimmo Tyni nimitetty BBS-Bioactive Bone Substitutes Oyj:n tuotantojohtajaksi
02 janv. 2024 09h30 HE | BBS-Bioactive Bone Substitutes Oyj
BBS-Bioactive Bone Substitutes Oyj, yhtiötiedote, 2.1.2024 klo 16.30 Kimmo Tyni nimitetty BBS-Bioactive Bone Substitutes Oyj:n tuotantojohtajaksi

 BBS-Bioactive Bone Substitutes Oyj:n...
BBS-Bioactive Bone S
BBS-Bioactive Bone Substitutes Plc: Merja Haikola appointed as Accountable Director (QP) of BBS-Bioactive Bone Substitutes Plc
27 déc. 2023 10h45 HE | BBS-Bioactive Bone Substitutes Oyj
BBS-Bioactive Bone Substitutes Plc, Company Announcement, 27 December 2023 at 05.45 PM (EET) Merja Haikola appointed as Accountable Director (QP) of BBS-Bioactive Bone Substitutes Plc ...
BBS-Bioactive Bone S
BBS-Bioactive Bone Substitutes Oyj: Merja Haikola nimitetty BBS-Bioactive Bone Substitutes Oyj:n Vastuunalaiseksi Johtajaksi /QP
27 déc. 2023 10h45 HE | BBS-Bioactive Bone Substitutes Oyj
BBS-Bioactive Bone Substitutes Oyj, yhtiötiedote, 27.12.2023 klo 17.45 Merja Haikola nimitetty BBS-Bioactive Bone Substitutes Oyj:n Vastuunalaiseksi Johtajaksi BBS-Bioactive Bone Substitutes...